Uroxatral (uro-ZEH-tral), a new alpha-blocker for benign prostatic hypertrophy

You'll soon see ads for Uroxatral (uro-ZEH-tral), a new alpha-blocker for benign prostatic hypertrophy.

It's the fourth alpha-blocker for BPH...along with Flomax (tamsulosin), Hytrin (terazosin), and Cardura (doxazosin).

They are all similarly effective for BPH...but the newer ones, Uroxatral (alfuzosin) and Flomax, seem to be better tolerated.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote